ACE and Alzheimer disease: Fortunately, while uncertainty remains on this issue, angiotensin-receptor blockers, which solely target ANG II effects whilst not interfering directly with ACE, could provide an immediate and readily available potential alternative anti-hypertensive therapy for patients at risk for AD [31-33].